Published in Thorax on August 01, 2001
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC | NCT02584699
Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer. Oncol Lett (2012) 0.95
Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. J Thorac Dis (2013) 0.94
Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer. PLoS One (2015) 0.88
Managed care and cancer outcomes for Medicare beneficiaries with disabilities. Am J Manag Care (2008) 0.88
Lung cancer 7: management of lung cancer in elderly patients. Thorax (2003) 0.84
A decade of advances in treatment of early-stage lung cancer. Clin Chest Med (2011) 0.82
Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer. CMAJ (2009) 0.81
Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy. Radiat Oncol (2015) 0.79
Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules. Cancer Res Treat (2016) 0.75
The lung cancer paradox: time for action. Thorax (2002) 0.75
Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer. Br J Radiol (2016) 0.75
Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy. J Oncol (2010) 0.75
Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? Transl Lung Cancer Res (2014) 0.75
Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer. Lung Cancer (Auckl) (2013) 0.75
Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis. Radiat Oncol (2015) 0.75
An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients. Br J Radiol (2016) 0.75
SBRT in operable early stage lung cancer patients. Transl Lung Cancer Res (2014) 0.75
Revisions in the International System for Staging Lung Cancer. Chest (1997) 15.68
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg (1995) 9.51
Randomized versus historical controls for clinical trials. Am J Med (1982) 7.53
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys (1998) 2.97
Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess (1998) 2.49
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol (1999) 2.43
Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys (1992) 2.30
Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1993) 1.95
Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1988) 1.83
Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys (1999) 1.82
Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy. Semin Radiat Oncol (1996) 1.62
Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys (1993) 1.51
High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results. Int J Radiat Oncol Biol Phys (1996) 1.44
Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys (1998) 1.36
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer (1995) 1.27
The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest (1995) 1.24
Results of surgical treatment in Stage I lung cancer. J Thorac Cardiovasc Surg (1977) 1.20
Radical radiotherapy for carcinoma of the bronchus: an equal alternative to radical surgery? Clin Oncol (R Coll Radiol) (1989) 1.10
Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys (1996) 0.97
Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys (1996) 0.97
Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (1990) 0.96
Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer (1999) 0.94
Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol (1997) 0.91
Survival analysis of untreated patients with non-small-cell lung cancer. Chest (1994) 0.90
Can lung cancer be cured by irradiation alone? JAMA (1966) 0.90
The present position relating to cancer of the lung. Results with radiotherapy alone. Thorax (1960) 0.89
Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol (1989) 0.89
Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol (1996) 0.89
Ten year follow-up of a comprehensive rehabilitation program for severe COPD. Chest (1980) 0.86
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1990) 0.82
Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 0.82
Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1997) 0.82
Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1995) 0.81
Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure. Acta Oncol (1995) 0.81
Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer (1992) 0.80
High-dose radiation therapy for inoperable non-small cell lung cancer without mediastinal involvement (clinical stage N0, N1). Strahlenther Onkol (1996) 0.80
Radiotherapy alone for patients with operable carcinoma of the lung. Chest (1985) 0.80
Results of radiotherapy with curative intent in non-small cell lung cancer. An analysis of 130 patients. Strahlenther Onkol (1992) 0.78
The effect of radiotherapy on the survival of non-small cell lung cancer patients. Int J Radiat Oncol Biol Phys (1998) 0.78
Radical radiotherapy for bronchogenic carcinoma: five year survival rates. Clin Oncol (R Coll Radiol) (1989) 0.78
Radical radiotherapy of inoperable non-small cell lung cancer. Irradiation techniques and tumor characteristics in relation to local control and survival. Acta Oncol (1992) 0.77
Radical radiotherapy for inoperable non-small cell lung cancer: what factors predict prognosis? Clin Oncol (R Coll Radiol) (2000) 0.77
Radiotherapy in inoperable stage I lung cancer. Jpn J Clin Oncol (1991) 0.77
Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol (1996) 0.77
Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy. Int J Radiat Oncol Biol Phys (1999) 0.77
The characteristics of long-term survivors of lung cancer treated with radiation. Cancer (1981) 0.77
High-dose radiation therapy alone for inoperable non-small cell lung cancer--experience with prolonged overall treatment times. Acta Oncol (1998) 0.76
Radiation therapy a good alternative for unoperable NSCLC. J Miss State Med Assoc (1990) 0.76
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet (2001) 5.71
Usefulness of letters from hospitals to general practitioners. Br Med J (Clin Res Ed) (1984) 4.01
Variability in automatic activation as an unobtrusive measure of racial attitudes: a bona fide pipeline? J Pers Soc Psychol (1995) 3.14
Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature (1983) 2.73
V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev (1996) 2.29
Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest (1995) 2.20
Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med (1977) 1.93
Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res (1991) 1.82
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta. J Biol Chem (1983) 1.71
Multiexon deletion in an osteogenesis imperfecta variant with increased type III collagen mRNA. J Biol Chem (1985) 1.67
Monitoring mRNA decapping activity. Methods (1999) 1.64
Evaluation of dietary influences on Escherichia coli O157:H7 shedding by sheep. Appl Environ Microbiol (1997) 1.60
Carboplatin or cisplatin? Lancet (1988) 1.53
Attitude accessibility as a moderator of the attitude-perception and attitude-behavior relations: an investigation of the 1984 presidential election. J Pers Soc Psychol (1986) 1.51
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51
Bilateral testicular germ cell tumours: an increasing incidence and prevention by chemotherapy. Br J Urol (1988) 1.42
Effect of cattle diet on Escherichia coli O157:H7 acid resistance. Appl Environ Microbiol (1999) 1.42
Developing new drugs for cancer. BMJ (1991) 1.39
First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet (1998) 1.32
A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer (1990) 1.28
Cis-platinum: a new anticancer agent. Br Med J (1979) 1.24
Mutations in VPS16 and MRT1 stabilize mRNAs by activating an inhibitor of the decapping enzyme. Mol Cell Biol (1999) 1.23
Epileptic seizures associated with cisplatin administration. Cancer Treat Rep (1982) 1.22
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol (1986) 1.22
Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science (1994) 1.20
Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med (1992) 1.19
Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet (1996) 1.16
Ruminant gastrointestinal cell proliferation and clearance of Escherichia coli O157:H7. Infect Immun (2000) 1.10
The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes (1996) 1.09
A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd. Br J Cancer (1984) 1.08
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev (2001) 1.03
Involvement of the gastrointestinal tract by metastases from germ cell tumors of the testis. Cancer (1988) 1.02
Comparison of analysis of variance and maximum likelihood based path analysis of twin data: partitioning genetic and environmental sources of covariance. Genet Epidemiol (1995) 1.01
Development of CD4+CD8+ thymocytes in RAG-deficient mice through a T cell receptor beta chain-independent pathway. J Exp Med (1995) 1.00
Response of differentiated but not anaplastic teratoma to interferon. Br J Cancer (1984) 1.00
Management of trials in the development of cancer chemotherapy. Br J Cancer (1978) 0.99
Acid resistance of Escherichia coli O157:H7 from the gastrointestinal tract of cattle fed hay or grain. Vet Microbiol (2003) 0.98
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev (2001) 0.97
Treatment of head-and-neck cancer. Lancet (1982) 0.96
Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers. Cancer Res (1976) 0.96
A phase II study of tamoxifen in ovarian cancer. Eur J Cancer Clin Oncol (1986) 0.96
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. Am J Hum Genet (1999) 0.96
The major structural proteins of murine mammary tumor virus: techniques for isolation. Anal Biochem (1977) 0.95
Increased collagen biosynthesis and increased expression of type I and type III procollagen genes in tight skin (TSK) mouse fibroblasts. J Biol Chem (1986) 0.95
Social contact and sibling similarity: facts, issues, and red herrings. Behav Genet (1990) 0.95
Desmoplastic small round cell tumour: obstetric and gynecological presentations. Gynecol Oncol (2006) 0.94
Estimating the prevalence of infections in vector populations using pools of samples. Med Vet Entomol (2012) 0.94
The leatherback turtle, Dermochelys coriacea, exhibits both polyandry and polygyny. Mol Ecol (2002) 0.93
Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. Br J Cancer (1988) 0.91
ChlVPP chemotherapy in advanced Hodgkin's disease. Eur J Cancer Clin Oncol (1989) 0.90
Genetic analysis of the resting electroencephalographic power spectrum in human twins. Psychophysiology (1996) 0.89
Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report. Cancer Treat Rep (1983) 0.88
Recent outbreaks of infectious syphilis, United Kingdom, January 2012 to April 2014. Euro Surveill (2014) 0.88
Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism. Cancer Res (1982) 0.86
Precise determination of 6Li cold collision parameters by radio-frequency spectroscopy on weakly bound molecules. Phys Rev Lett (2005) 0.86
Five families with arginine 519-cysteine mutation in COL2A1: evidence for three distinct founders. Hum Mutat (1998) 0.85
Preventing lung cancer. Br Med J (Clin Res Ed) (1987) 0.85
Clinical features and management of malignant histiocytosis of the intestine. Cancer (1987) 0.85
Chemotherapy of advanced ovarian carcinoma: initial experience using a platinum-based combination. Cancer (1982) 0.84
Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine. Cancer Treat Rep (1985) 0.84
Prepartum supplementation of selenium and vitamin E to dairy cows: assessment of selenium status and reproductive performance. J Dairy Sci (1987) 0.84
Gendered sex work in the San Francisco tenderloin. Arch Sex Behav (1999) 0.84
Involvement of the central nervous system by non-Hodgkin's lymphoma in adults. A review of 36 cases. Q J Med (1986) 0.83
Mutation screening and identification of a sequence variation in the human ob gene coding region. Biochem Biophys Res Commun (1996) 0.83
Extensive stage small cell carcinoma of the bronchus. A randomised study of etoposide given orally by one-day or five-day schedule together with intravenous adriamycin and cyclophosphamide. Cancer Chemother Pharmacol (1987) 0.83
Study of the mechanisms of cadmium biosorption by dealginated seaweed waste. Environ Sci Technol (2001) 0.82
Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling. Br Med J (Clin Res Ed) (1982) 0.82
Prevalence and prognostic significance of anticardiolipin antibodies in pregnancies complicated by human immunodeficiency virus-1 infection. Am J Obstet Gynecol (1992) 0.81
Pharmacokinetics and amounts of 25-hydroxycholecalciferol in sheep affected by osteodystrophy. J Dairy Sci (1979) 0.81
A single base mutation in the type II procollagen gene (COL2A1) that converts glycine alpha 1-247 to serine in a family with late-onset spondyloepiphyseal dysplasia. Hum Mutat (1994) 0.81
Poor prognosis non-Hodgkin's lymphoma in the elderly: clinical presentation and management. Q J Med (1984) 0.81
Mathematical model of a gene regulatory network reconciles effects of genetic perturbations on hematopoietic stem cell emergence. Dev Biol (2013) 0.81
Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies. Hybridoma (1991) 0.81
Combination chemotherapy using high or low dose methotrexate for small cell carcinoma of the lung--a randomised trial. Med Oncol Tumor Pharmacother (1984) 0.81
Correlations between clonogenicity and prognostic factors in human breast cancer. Br J Surg (1984) 0.80
Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. Int J Radiat Oncol Biol Phys (1988) 0.80
Intrapair differences in personality and cognitive ability among young monozygotic twins distinguished by chorion type. Behav Genet (1995) 0.79
Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients. Cancer Treat Rep (1980) 0.79
Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues. Int J Cancer (1992) 0.79
Homosexual foot fetishism. Arch Sex Behav (1994) 0.79
Handling cytotoxics. Br Med J (Clin Res Ed) (1985) 0.79
Population distribution of placental benzo(a)pyrene metabolism in smokers. Int J Cancer (1983) 0.79
Heritability estimates from human twin data by incorporating historical prior information. Biometrics (1998) 0.79
A report on a prospective trial of no initial therapy in patients with initial therapy in patients with asymptomatic favourable prognosis non-Hodgkin's lymphoma. Hematol Oncol (1984) 0.78
Implications of an overview of chemotherapy in advanced ovarian carcinoma. Br J Cancer (1992) 0.78
Bone mass and anthropometric measurements in adult females. Bone Miner (1990) 0.78
High density lipoprotein cholesterol. A 16-year longitudinal study in aging male twins. Arteriosclerosis (1990) 0.78
Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues. Cancer Res (1978) 0.78
High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot study. Br J Cancer (1990) 0.78
Acute Listeria monocytogenes osteomyelitis. Infection (1976) 0.78
Arg519-Cys mutation in COL2A1: evidence for multiple founders. Ann N Y Acad Sci (1996) 0.78
Response to five generations of selection for blood cholesterol levels in White Leghorns. Poult Sci (1980) 0.78
Do authors of review articles use systematic methods to identify, assess and synthesize information? Ann Oncol (1997) 0.77
MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures. J Cell Physiol (2010) 0.77
Characterization of purified structural proteins of murine mammary tumor virus. Virology (1979) 0.77
Low measles, mumps and rubella (MMR) vaccine uptake in hospital healthcare worker contacts following suspected mumps infection. J Hosp Infect (2010) 0.77
Substrate-dependent utilization of the glycerol 3-phosphate or malate/aspartate redox shuttles by Ehrlich ascites cells. Biochem J (1995) 0.77
Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment. Br J Cancer (1989) 0.77